Dr. Edmond A. Bendaly, MD

Dr. Bendaly practices at Marion Health in Marion, Indiana, part of Marion General Hospital.

Dr. Bendaly's NPI, 1285835652, was assigned on May 31, 2007. Dr. Bendaly graduated from American University of Beirut Faculty of Medicine in 2001. Dr. Bendaly holds New York license P51816.

Dr. Bendaly's primary practice is Marion Health, at 441 N Wabash Ave, Marion, IN 46952 in Grant County. The practice phone is (765) 660-6000.

Dr. Bendaly's primary practice is Marion Health in Marion, Indiana, part of Marion General Hospital. The medical group on file is Physicians' Billing of Marion Health. Dmand AI also links Dr. Bendaly to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bendaly practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Bendaly's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Bendaly is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Bendaly's licenses on file in 4 states: New York, Indiana, Maine and Rhode Island.

Dmand AI lists arterial blot clot /embolism, breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease and lung cancer among the conditions Dr. Bendaly treats.

CMS data shows 1,288 Medicare services from Dr. Bendaly across 7 procedure codes in 2024, for 313 Medicare patients. Medicare paid $102,241 for them.

CMS counts 313 Medicare patients who saw Dr. Bendaly in 2024. The largest group is 65 to 74, with 138 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bendaly's median patient age at 68, with 57% women.

In 2024, Dr. Bendaly wrote 1,907 Medicare Part D claims for 231 patients. 85% of them were for generic drugs. CMS names the drug for 1,655 of them, across 40 drugs with 11 or more claims each, at $1,966,675 in total drug cost. In 2023, CMS named 1,211 claims across 35 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Bendaly for performance year 2024, reported as part of a group. Dr. Bendaly accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Bendaly, published from 2016 to 2017. 2017 was the busiest year, with 3. The most frequent topics are Carcinoma, Non-Small-Cell Lung, Lung Neoplasms and Crizotinib. Dr. Bendaly has published most often in Adv Ther. Dr. Bendaly's most frequent co-authors are Khalil J. Diab, MD, Nawar Al Nasrallah, MD and Rita Assi, MD.

CMS Open Payments shows 996 general payments to Dr. Bendaly from 64 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 58% of the total. Bristol-Myers Squibb Company paid the most, $23,995. It also lists 9 research payments totaling $23,468 from 2016 to 2017.

Dr. Bendaly graduated from American University of Beirut Faculty of Medicine in 2001. Dr. Bendaly is a member of ACP.

Dr. Bendaly is in network with 15 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.